On January 5, 2026, Skye Bioscience Inc. and Halozyme Therapeutics Inc. announced a global non-exclusive collaboration and licensing agreement to... Read more
Tag: #Global Trends
Fujifilm Irvine Scientific officially rebrands as Fujifilm Biosciences
As of January 5, 2026, Fujifilm Irvine Scientific Inc. has formally changed its legal name to Fujifilm Biosciences Inc. This... Read more
Daiichi Sankyo commits $1.9bn to expand global cancer drug manufacturing
On January 5, 2026, Japanese pharmaceutical firm Daiichi Sankyo unveiled a major investment plan of approximately $1.9 billion (300 billion... Read more
Sanofi enters $2.56bn AI-driven partnership for autoimmune therapies
Pharmaceutical giant Sanofi has signed a significant collaboration deal with Earendil Labs, a biotech startup, to leverage bispecific antibody technology... Read more
U.S. CDC revises childhood immunization schedule
On January 5, 2026, the Centers for Disease Control and Prevention (CDC) announced a major overhaul of the national childhood... Read more
FDA grants priority review for Sanofi’s Tzield to expand use in toddlers with stage 2 type 1 diabetes
On January 5, 2026, Sanofi announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review the... Read more
Insilico Medicine and Servier ink $888M cancer research pact
Fresh from its successful IPO in Hong Kong, AI-driven biotech Insilico Medicine has kicked off the year by entering an... Read more
Top health priorities based on 2025 online search data
The evolution of digital self-care In 2025, global health search patterns shifted from simple symptom checks to a deeper demand... Read more
Ai implementation for pancreatic cancer screening in China
The shift to AI diagnostics China's medical landscape is rapidly evolving by integrating AI tools into daily clinical routines. The... Read more









